Related Articles
The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
Urantide decreases hepatic steatosis in rats with experimental atherosclerosis via the MAPK/Erk/JNK pathway
The peptide compound urantide regulates collagen metabolism in atherosclerotic rat hearts and inhibits the JAK2/STAT3 pathway
Urantide prevents CCl4‑induced acute liver injury in rats by regulating the MAPK signalling pathway
Activation of corticotropin-releasing factor receptor 1 aggravates dextran sodium sulphate-induced colitis in mice by promoting M1 macrophage polarization